Related Experiment Video
Updated: Dec 14, 2025

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs
Tommaso Felicetti1, Violetta Cecchetti1, Giuseppe Manfroni1
1Department of Pharmaceutical Sciences, University of Perugia, via del Liceo 1, 06123 Perugia, Italy.
Abstract:
The RNA interference (RNAi) process encompasses the cellular mechanisms by which short-noncoding RNAs posttranscriptionally modulate gene expression. First discovered in 1998, today RNAi represents the foundation underlying complex biological mechanisms that are dysregulated in many diseases. MicroRNAs are effector molecules of gene silencing in RNAi, and their modulation can lead to a wide response in cells. Enoxacin was reported as the first and unique small-molecule enhancer of microRNA (SMER) maturation. Herein, the biological activity of enoxacin as SMER is discussed to shed light on its innovative mode of action, its potential in treating different diseases, and the feasibility of using enoxacin as a chemical template for inspiring medicinal chemists. We debate its mechanism of action at the molecular level and the possible impact on future ligand and/or structure-guided chemical optimizations, as well as opportunities and drawbacks associated with the development of quinolones such as SMERs.
Insights
Enoxacin enhances microRNA maturation, offering a novel therapeutic strategy for diseases linked to RNA interference pathway dysregulation. Its potential as a chemical template for drug development is explored.
Area of Science:
- Molecular Biology
- Pharmacology
- Genetics
Background:
- RNA interference (RNAi) is a fundamental biological process regulating gene expression via short non-coding RNAs.
- Dysregulation of RNAi pathways, particularly microRNAs, is implicated in various human diseases.
- Enoxacin is identified as the first small-molecule enhancer of microRNA (SMER) maturation.
Purpose of the Study:
- To elucidate the biological activity and innovative mechanism of action of enoxacin as a SMER.
- To assess the therapeutic potential of enoxacin in treating diseases associated with microRNA dysregulation.
- To evaluate enoxacin as a chemical template for medicinal chemistry and drug discovery.
Main Methods:
- Review and discussion of existing literature on enoxacin's biological activity.
- Molecular-level analysis of enoxacin's mechanism of action as a SMER.
- Exploration of structure-activity relationships and potential for chemical optimization.
Main Results:
- Enoxacin demonstrates a unique mode of action in enhancing microRNA maturation.
- The study highlights enoxacin's potential for therapeutic applications in various diseases.
- Enoxacin serves as a valuable chemical scaffold for developing novel SMERs.
Conclusions:
- Enoxacin represents a pioneering SMER with significant therapeutic promise.
- Further research into enoxacin and related quinolones could lead to new drug development strategies.
- The development of quinolone-based SMERs presents both opportunities and challenges for medicinal chemists.
Related Concept Videos
MicroRNAs
MicroRNAs
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Gene Regulation in Microbial Communities: Quorum Sensing
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Experimental RNAi

